11:03 AM
Sep 28, 2018
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Gene therapy play LogicBio proposes IPO

Gene therapy company LogicBio Therapeutics Inc. (Cambridge, Mass.) proposed to raise up to $86 million in an IPO on NASDAQ underwritten by Jefferies, Barclays, William Blair and Chardan.

LogicBio is developing gene therapies to address rare diseases, particularly rare liver disorders in pediatric patients, using its GeneRide technology. GeneRide uses homologous recombination to link a therapeutic transgene to the endogenous albumin promoter to deliver and integrate genetic material without...

Read the full 323 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >